Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Immunology | Pediatrics/Neonatology | Vaccines
Disease Category: Vaccines
Location: United States, NC

Clinical Trial Details


Research Study Summary

Meningococcal Meningitis Vaccine – Ages 10-55


A research study is evaluating an investigational vaccine for meningococcal meningitis.

To Learn more

CW ID: 214254
Date Last Changed: July 28, 2016

Clinical Trial Snapshot

Both Male and Female
10 to 55 Years
Overall Status
6 Months
Facility Type


This research study may be an option if you:

  • Are between 10 and 55 years of age
  • Are generally healthy
  • Have not previously received any kind of vaccine for meningococcal disease or have a history of meningococcal infection
  • Do not have a sensitivity to latex
  • Do not have a history of Guillain-Barre syndrome (GBS)

Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.

Qualified participants will receive all study-related care and study vaccine or Menactra® vaccine at no cost.

More Info

Financial compensation may be provided for time and travel expenses.


PMG Research of Raleigh
3521 Haworth Drive, Suite 100
Raleigh, NC 27609
Phone: 919-783-4895

View Map

Research Center Information:

PMG Research of Raleigh

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.